157 related articles for article (PubMed ID: 28763838)
1. [Modern knowledge and development trend of intrahepatic cholangiocellular carcinoma].
Wang Q; Zhou HB; Hu HP
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):336-338. PubMed ID: 28763838
[TBL] [Abstract][Full Text] [Related]
2. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
[TBL] [Abstract][Full Text] [Related]
3. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
Maeda Y; Nishida M; Mori N; Tamesa T; Okada T; Tangoku A; Oka M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():401-5. PubMed ID: 11761981
[No Abstract] [Full Text] [Related]
4. Clinicopathological Features and Prognosis of Intrahepatic Cholangiocarcinoma After Liver Transplantation and Resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Ann Transplant; 2017 Jan; 22():42-52. PubMed ID: 28123170
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study.
Yin X; Zheng SS; Zhang BH; Zhou Y; Chen XH; Ren ZG; Qiu SJ; Fan J
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1408-14. PubMed ID: 23839159
[TBL] [Abstract][Full Text] [Related]
6. Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma.
Zhang H; Jenkins SM; Lee CT; Harrington SM; Liu Z; Dong H; Zhang L
Hum Pathol; 2018 Aug; 78():97-105. PubMed ID: 29698699
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
10. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer.
Yang Z
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
[TBL] [Abstract][Full Text] [Related]
12. Surveillance in cholangiocellular carcinoma.
Wirth TC; Vogel A
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):987-999. PubMed ID: 27938792
[TBL] [Abstract][Full Text] [Related]
13. [Primary liver tumors : hepatocellular versus intrahepatic cholangiocellular carcinoma].
Wengert GJ; Bickel H; Breitenseher J; Ba-Ssalamah A
Radiologe; 2015 Jan; 55(1):27-35. PubMed ID: 25575724
[TBL] [Abstract][Full Text] [Related]
14. [Current status and future perspectives on the methods of prognosis evaluation for intrahepatic cholangiocarcinoma].
Ji GW; Xu ZG; Cao SY; Wang K; Wang XH
Zhonghua Wai Ke Za Zhi; 2023 Jun; 61(6):467-473. PubMed ID: 37088478
[TBL] [Abstract][Full Text] [Related]
15. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma.
Sueoka H; Hirano T; Uda Y; Iimuro Y; Yamanaka J; Fujimoto J
Surgery; 2014 Apr; 155(4):640-9. PubMed ID: 24582495
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
17. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
Seo N; Kim DY; Choi JY
AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
[TBL] [Abstract][Full Text] [Related]
19. [New advances in the diagnosis and treatment of intrahepatic cholangiocarcinoma].
Qin DL; Chen JL; Tang Y; Li ZL; Tang ZH; Quan ZW
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):331-337. PubMed ID: 38432675
[TBL] [Abstract][Full Text] [Related]
20. Subcentimetric Incidental Intrahepatic Cholangiocarcinoma in an Explant Liver: Diagnostic Difficulty of a Rare Entity.
Mitra S; Geethanjali G; Rathi S; Behera A; Das A
Int J Surg Pathol; 2018 Dec; 26(8):739-744. PubMed ID: 29742944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
